Matt O'Brien
Stock Analyst at Piper Sandler
(2.09)
# 2,842
Out of 5,182 analysts
204
Total ratings
39.29%
Success rate
-6.23%
Average return
Main Sectors:
Stocks Rated by Matt O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADGM Adagio Medical Holdings | Initiates: Overweight | $3 | $1.15 | +160.87% | 1 | Apr 14, 2026 | |
| MDT Medtronic | Maintains: Neutral | $105 → $91 | $82.92 | +9.74% | 10 | Apr 1, 2026 | |
| MMED MiniMed Group | Initiates: Neutral | $16 | $12.92 | +23.84% | 1 | Mar 31, 2026 | |
| TELA TELA Bio | Maintains: Neutral | $1.25 → $1 | $0.80 | +25.05% | 8 | Mar 25, 2026 | |
| CNMD CONMED | Downgrades: Neutral | $55 → $39 | $37.87 | +2.98% | 15 | Mar 17, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Overweight | $21 → $33 | $19.82 | +66.50% | 11 | Mar 17, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $50 → $28 | $24.09 | +16.23% | 6 | Feb 26, 2026 | |
| TMDX TransMedics Group | Maintains: Overweight | $140 → $160 | $108.12 | +47.98% | 14 | Feb 25, 2026 | |
| GMED Globus Medical | Reiterates: Overweight | $90 → $115 | $93.70 | +22.73% | 13 | Jan 8, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Overweight | $27 → $30 | $22.23 | +34.95% | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $18 | $13.53 | +33.04% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $75 | $61.41 | +22.13% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 → $25 | $10.36 | +141.31% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $26 → $32 | $10.65 | +200.47% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $155 → $82 | $85.35 | -3.93% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $22 | $15.82 | +39.06% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $9.86 | +82.56% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $12 | $7.65 | +56.86% | 9 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $165 | $122.07 | +35.17% | 10 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $3.5 | $4.32 | -18.98% | 7 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $255 → $140 | $135.07 | +3.65% | 5 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $310 | $188.31 | +64.62% | 8 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $250 → $330 | $327.98 | +0.62% | 13 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $50 | $29.04 | +72.18% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $16 | $26.68 | -40.03% | 7 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $115 | $59.95 | +91.83% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $9 → $12 | $4.56 | +163.16% | 7 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $380 → $420 | $329.01 | +27.66% | 12 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $25 | $13.15 | +90.11% | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $3 | $0.81 | +272.25% | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $4.5 | $3.76 | +19.68% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $92.59 | - | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $4.10 | +265.85% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $109 | $64.34 | +69.02% | 1 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $80 | $18.49 | +332.67% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $12 | $4.06 | +195.57% | 1 | Jun 24, 2020 |
Adagio Medical Holdings
Apr 14, 2026
Initiates: Overweight
Price Target: $3
Current: $1.15
Upside: +160.87%
Medtronic
Apr 1, 2026
Maintains: Neutral
Price Target: $105 → $91
Current: $82.92
Upside: +9.74%
MiniMed Group
Mar 31, 2026
Initiates: Neutral
Price Target: $16
Current: $12.92
Upside: +23.84%
TELA Bio
Mar 25, 2026
Maintains: Neutral
Price Target: $1.25 → $1
Current: $0.80
Upside: +25.05%
CONMED
Mar 17, 2026
Downgrades: Neutral
Price Target: $55 → $39
Current: $37.87
Upside: +2.98%
Tandem Diabetes Care
Mar 17, 2026
Upgrades: Overweight
Price Target: $21 → $33
Current: $19.82
Upside: +66.50%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $50 → $28
Current: $24.09
Upside: +16.23%
TransMedics Group
Feb 25, 2026
Maintains: Overweight
Price Target: $140 → $160
Current: $108.12
Upside: +47.98%
Globus Medical
Jan 8, 2026
Reiterates: Overweight
Price Target: $90 → $115
Current: $93.70
Upside: +22.73%
Kestra Medical Technologies
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $30
Current: $22.23
Upside: +34.95%
Nov 12, 2025
Reiterates: Overweight
Price Target: $18
Current: $13.53
Upside: +33.04%
Oct 31, 2025
Maintains: Overweight
Price Target: $100 → $75
Current: $61.41
Upside: +22.13%
Oct 31, 2025
Reiterates: Overweight
Price Target: $20 → $25
Current: $10.36
Upside: +141.31%
Oct 29, 2025
Reiterates: Overweight
Price Target: $26 → $32
Current: $10.65
Upside: +200.47%
Oct 24, 2025
Maintains: Overweight
Price Target: $155 → $82
Current: $85.35
Upside: -3.93%
Oct 10, 2025
Maintains: Overweight
Price Target: $30 → $22
Current: $15.82
Upside: +39.06%
Aug 18, 2025
Initiates: Overweight
Price Target: $18
Current: $9.86
Upside: +82.56%
May 9, 2025
Maintains: Overweight
Price Target: $20 → $12
Current: $7.65
Upside: +56.86%
Apr 15, 2025
Maintains: Overweight
Price Target: $180 → $165
Current: $122.07
Upside: +35.17%
Mar 6, 2025
Maintains: Neutral
Price Target: $5.5 → $3.5
Current: $4.32
Upside: -18.98%
Feb 28, 2025
Downgrades: Neutral
Price Target: $255 → $140
Current: $135.07
Upside: +3.65%
Feb 21, 2025
Maintains: Overweight
Price Target: $285 → $310
Current: $188.31
Upside: +64.62%
Feb 19, 2025
Reiterates: Overweight
Price Target: $250 → $330
Current: $327.98
Upside: +0.62%
Feb 13, 2025
Maintains: Overweight
Price Target: $40 → $50
Current: $29.04
Upside: +72.18%
Feb 12, 2025
Maintains: Neutral
Price Target: $40 → $16
Current: $26.68
Upside: -40.03%
Feb 3, 2025
Maintains: Overweight
Price Target: $95 → $115
Current: $59.95
Upside: +91.83%
Nov 8, 2024
Reiterates: Neutral
Price Target: $9 → $12
Current: $4.56
Upside: +163.16%
Oct 30, 2024
Reiterates: Overweight
Price Target: $380 → $420
Current: $329.01
Upside: +27.66%
Mar 28, 2024
Initiates: Overweight
Price Target: $25
Current: $13.15
Upside: +90.11%
Nov 10, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $0.81
Upside: +272.25%
Aug 11, 2023
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.76
Upside: +19.68%
Mar 10, 2023
Upgrades: Overweight
Price Target: n/a
Current: $92.59
Upside: -
Feb 24, 2023
Initiates: Overweight
Price Target: $15
Current: $4.10
Upside: +265.85%
Feb 11, 2021
Maintains: Overweight
Price Target: $93 → $109
Current: $64.34
Upside: +69.02%
Jan 29, 2021
Downgrades: Neutral
Price Target: $100 → $80
Current: $18.49
Upside: +332.67%
Jun 24, 2020
Initiates: Overweight
Price Target: $12
Current: $4.06
Upside: +195.57%